Journal Article

Reproductive and Oncologic Outcomes in Young Women with Stage IA and Grade 2 Endometrial Carcinoma Undergoing Fertility-Sparing Treatment: A Systematic Review

Chiantera, Vito, d’Amati, Antonio, Mikuš, Mislav, Favilli, Alessandro, Vitagliano, Amerigo, Arsalan, Hafiz Muhammad, Etrusco, Andrea, Laganà, Antonio Simone, D’Amato, Antonio, Cicinelli, Ettore

2024

Overview

Background: Endometrial cancer (EC) is the most common gynecological malignancy in both Europe and the USA. Approximately 3–5% of cases occur in women of reproductive age. Fertility-sparing treatment (FST) options are available, but very limited evidence regarding grade 2 (G2) ECs exists in the current literature. This systematic review aimed to comprehensively evaluate reproductive and oncologic outcomes among young women diagnosed with stage IA or G2EC disease who underwent FST. Methods: A comprehensive search of the literature was carried out on the following databases: MEDLINE, EMBASE, Global Health, The Cochrane Library (Cochrane Database of Systematic Reviews, Cochrane Central Register of Controlled Trials, Cochrane Methodology Register), the Health Technology Assessment Database, and Web of Science. Only original studies that reported the oncologic and reproductive outcomes of patients with stage IA and G2EC tumors who underwent FST were considered eligible for inclusion in this systematic review (CRD42023484892). Studies describing only the FST for endometrial hyperplasia or G1 EC were excluded. Results: Twenty-two papers that met the abovementioned inclusion criteria were included in the present systematic review. Preliminary analysis suggested encouraging oncologic and reproductive outcomes after FST. Conclusions: The FST approach may represent a feasible and safe option for women of childbearing age diagnosed with G2EC. Despite these promising findings, cautious interpretation is warranted due to inherent limitations, including heterogeneity in study designs and potential biases. Further research with standardized methodologies and larger sample sizes is imperative for obtaining more robust conclusions.

• Publisher: MDPI AG,MDPI
• Subject: Adult / Cancer / Cancer therapies / Care and treatment / Classification / Clinical trials / Endometrial cancer / Endometrial Neoplasms - pathology / Endometrium / Evaluation / Female / Fertility / Fertility Preservation - methods / Fertility, Human / fertility-sparing treatment / grade 2 / Gynecological cancer / Gynecology / Health aspects / hormonal therapy / Humans / Hyperplasia / Intrauterine devices / IUD / Malignancy / Neoplasm Grading / Neoplasm Staging / oncologic outcomes / Pregnancy / Public health / reproductive outcomes / Systematic Review / Technology assessment / Treatment Outcome / Tumors / Uterine cancer / Womens health / Young women